Menzel Garry E insider trades
Menzel Garry E has filed 24 Form 4s with the SEC that we hold, for TCRR (President and CEO, Director), Adaptimmune Therapeutics PLC (ADAP) (Director), Black Diamond Therapeutics, Inc. (BDTX) (Director) and Stoke Therapeutics, Inc. (STOK) (Director). Across all of them we count 0 purchases worth $0 and 9 sales worth $145.2K reported on Form 4. None of these purchases or sales is dated in the last 12 months. The largest single trade was a sale of 47,702 shares of Adaptimmune Therapeutics PLC worth $43.4K, dated 2023-07-10. The first filing on our record is dated 2021-12-10 and the latest 2026-06-29.
TCRR
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2022-12-02 | S, sale reported on Form 4 | 8,408 | $11.7K | 2022-12-05 |
| 2022-12-05 | S, sale reported on Form 4 | 8,530 | $11.7K | 2022-12-07 |
| 2022-12-06 | S, sale reported on Form 4 | 14,886 | $20.1K | 2022-12-07 |
| 2022-12-07 | S, sale reported on Form 4 | 9,111 | $11.7K | 2022-12-09 |
| 2022-12-08 | S, sale reported on Form 4 | 9,314 | $11.6K | 2022-12-09 |
| 2022-12-09 | S, sale reported on Form 4 | 10,325 | $11.7K | 2022-12-13 |
| 2022-12-12 | S, sale reported on Form 4 | 10,613 | $11.7K | 2022-12-13 |
| 2022-12-13 | S, sale reported on Form 4 | 11,000 | $11.7K | 2022-12-13 |
Adaptimmune Therapeutics PLC (ADAP)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2023-07-10 | S, sale reported on Form 4 | 47,702 | $43.4K | 2023-07-10 |
Black Diamond Therapeutics, Inc. (BDTX)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Stoke Therapeutics, Inc. (STOK)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Counted from the Form 4 filings this reporting owner (SEC CIK 1556064) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms